» Articles » PMID: 33140004

Point-of-care Biosensors in Medicine: a Brief Overview of Our Achievements in This Field Based on the Conducted Research in EMRI (endocrinology and Metabolism Research Institute of Tehran University of Medical Sciences) over the Past Fourteen Years

Overview
Specialty Endocrinology
Date 2020 Nov 3
PMID 33140004
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The growing demand of diagnostic tools with enhanced analytical characteristics in term of sensitivity, selectivity, and low response time has encouraged researches to conduct their research towards development of point-of-care (POC) biosensors. POC diagnostic devices are powerful tools for detection, diagnosis, and monitoring of diseases at its initial stage. The above characteristics encouraged us to conduct active multidisciplinary and collaborative research oriented towards the design and development of POC sensing systems. Here, we present a brief overview of our recent achievement in the field of biomedical POC devices implemented in paper based microfluidic and screen printing electrodes and discuss the critical limitations that need to be surmounted to facilitate their translation into clinical practice in the future.

Citing Articles

Exploiting the Specificity of CRISPR/Cas System for Nucleic Acids Amplification-Free Disease Diagnostics in the Point-of-Care.

Yee B, Ali N, Mohd-Naim N, Ahmed M Chem Bio Eng. 2025; 1(4):330-339.

PMID: 39974464 PMC: 11835143. DOI: 10.1021/cbe.3c00112.


A 3D-Printed Do-It-Yourself ELISA Plate Reader as a Biosensor Tested on TNFα Assay.

Pohanka M, Kerestes O, Zakova J Biosensors (Basel). 2024; 14(7).

PMID: 39056607 PMC: 11274727. DOI: 10.3390/bios14070331.


Biopolymer-protected graphene-FeO nanocomposite based wearable microneedle sensor: toward real-time continuous monitoring of dopamine.

M R K, Panicker L, Narayan R, Kotagiri Y RSC Adv. 2024; 14(10):7131-7141.

PMID: 38414985 PMC: 10898425. DOI: 10.1039/d4ra00110a.


Reviewing the state of biosensors and lab-on-a- chip technologies: opportunities for extreme environments and space exploration.

Cinti S, Singh S, Covone G, Tonietti L, Ricciardelli A, Cordone A Front Microbiol. 2023; 14:1215529.

PMID: 37664111 PMC: 10470837. DOI: 10.3389/fmicb.2023.1215529.


Electrochemical biosensors in healthcare services: bibliometric analysis and recent developments.

Yunus G, Singh R, Raveendran S, Kuddus M PeerJ. 2023; 11:e15566.

PMID: 37397018 PMC: 10312160. DOI: 10.7717/peerj.15566.


References
1.
Omidfar K, Khorsand B, Larijani B . Development of a new sensitive immunostrip assay based on mesoporous silica and colloidal Au nanoparticles. Mol Biol Rep. 2011; 39(2):1253-9. DOI: 10.1007/s11033-011-0856-5. View

2.
Syedmoradi L, Daneshpour M, Alvandipour M, Gomez F, Hajghassem H, Omidfar K . Point of care testing: The impact of nanotechnology. Biosens Bioelectron. 2016; 87:373-387. DOI: 10.1016/j.bios.2016.08.084. View

3.
Omidfar K, Kia S, Larijani B . Development of a colloidal gold-based immunochromatographic test strip for screening of microalbuminuria. Hybridoma (Larchmt). 2011; 30(2):117-24. DOI: 10.1089/hyb.2010.0090. View

4.
Khodaei R, Ahmady A, Khoshfetrat S, Kashanian S, Tavangar S, Omidfar K . Voltammetric immunosensor for E-cadherin promoter DNA methylation using a FeO-citric acid nanocomposite and a screen-printed carbon electrode modified with poly(vinyl alcohol) and reduced graphene oxide. Mikrochim Acta. 2019; 186(3):170. DOI: 10.1007/s00604-019-3234-y. View

5.
Daneshpour M, Moradi L, Izadi P, Omidfar K . Femtomolar level detection of RASSF1A tumor suppressor gene methylation by electrochemical nano-genosensor based on Fe3O4/TMC/Au nanocomposite and PT-modified electrode. Biosens Bioelectron. 2015; 77:1095-103. DOI: 10.1016/j.bios.2015.11.007. View